SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 20th, 2015 • Oxigene Inc • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 20, 2015, between OXiGENE, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
AMENDMENT NO. 9 TO STOCKHOLDER RIGHTS AGREEMENTStockholder Rights Agreement • March 20th, 2015 • Oxigene Inc • Biological products, (no disgnostic substances) • Delaware
This Amendment No. 9 to Stockholder Rights Agreement (the “Amendment”), dated as of March 20, 2015 by and between OXiGENE, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC (the “Rights Agent”), amends that certain Stockholder Rights Agreement, dated as of March 24, 2005, as amended as of October 1, 2008, October 14, 2009, March 10, 2010, January 18, 2011, November 28, 2011, April 11, 2013, September 20, 2013 and May 22, 2014 by and between the Company and the Rights Agent (as so amended, the “Agreement”).
